INTRODUCTION
Malaria remains one of the world's most important infectious diseases, affecting $200 million people worldwide annually (WHO, 2018) . When Plasmodium falciparum, one of the most virulent forms of the human malaria parasite, establishes infection in host erythrocytes, the parasites export numerous proteins to the host cell's cytoplasm and plasma membrane to drastically remodel the host cell (Hiller et al., 2004; Maier et al., 2009) . These exported proteins are collectively referred to as the exportome, and some of these proteins form a large protein complex that leads to profound structural and morphological changes in the host erythrocytes (LaCount et al., 2005) ; for example, Maurer's clefts (Lanzer et al., 2006) and knobs (Wickham et al., 2001) are established in the cytoplasm and on the surface of erythrocytes, respectively. Consequently, the infected erythrocytes become more rigid and adhere to the vascular endothelium, which prevents clearance of the infected erythrocytes by the spleen and subsequently disrupts normal blood flow, resulting in severe malaria in humans (De Niz et al., 2016; .
The adherence of infected erythrocytes to the vascular endothelium is mediated by interactions between parasite adhesins on the erythrocyte surface and host endothelial receptors (Fairhurst et al., 2005; . Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is an antigenically variant adhesin that is transported to knobs on the erythrocyte surface (Waller et al., 1999) . Knobs are macromolecular complexes of knob-associated histidine-rich protein (KAHRP) that anchor PfEMP1 to the membrane skeleton (Oh et al., 2000; Waller et al., 1999) . In contrast, Maurer's clefts are involved in the trafficking of PfEMP1 to the erythrocyte surface (Lanzer et al., 2006; Wickham et al., 2001) . Many exported proteins, represented by skeleton-binding protein 1 (SBP1) Maier et al., 2007) , membrane-associated histidine-rich protein 1 (MAHRP1) (Spycher et al., 2008) , ring-exported protein 1 (REX1) , subtelomeric variant open reading frame (STEVOR) (Przyborski et al., 2005) , and PfEMP1-trafficking protein 1 and 5 (PTP1 and PTP5) , have been shown to reside in Maurer's clefts. Some of these exported proteins are essential for the intracellular transport of PfEMP1 to the erythrocyte surface, suggesting that they form a large protein complex in the Maurer's clefts that serves as protein-trafficking machinery to transport exported proteins to their final destinations . However, essential information regarding the interactions between these exported proteins is lacking, because of the technical difficulties of studying protein-protein interactions in the cytoplasm of erythrocytes infected with Plasmodium falciparum .
The P. falciparum exportome had been predicted to comprise approximately 400 proteins since the discovery of a motif sequence called PEXEL (P. falciparum exported elements) or HT (host-targeting sequence), which is conserved at the N-terminal end of many exported proteins (Hiller et al., 2004; . However, a previous study also identified the presence of many proteins that lack the canonical PEXEL/HT motif but could be efficiently exported to host cytoplasm , thereby complicating the identification of the exported proteins that comprise the P. falciparum exportome. These PEXEL-negative exported proteins (PNEPs) include SBP1, MAHRP1, and REX1, all of which are related to and are indispensable for malaria virulence Hanssen et al., 2008; Maier et al., 2007; Spycher et al., 2008) . Given the difficulty to predict and identify PNEPs based on protein sequences, an alternative approach is needed to directly identify PNEPs based on protein-protein interactions in the host cytoplasm.
In this study, we developed an alternative proteomic approach to identify exported proteins involved in the trafficking complex and to clarify the P. falciparum exportome. Highly sensitive mass spectrometry identified multiple proteins that interact with SBP1 through its intraerythrocytic-trafficking process. Further interaction, localization, and functional assays demonstrated that the SBP1 interactomes established in our study represent a powerful and invaluable platform to identify exported proteins related to severe malaria caused by P. falciparum.
RESULTS

A High-Resolution Map of SBP1 Interactomes
To identify proteins that interact with SBP1, we preformed FLAG-tag-based immunoprecipitations with lysates of erythrocytes infected with parasites overexpressing C-terminally FLAG-tagged SBP1 (SBP1-FLAG), and analyzed the co-immunoprecipitated proteins by mass spectrometry . We first generated parasites episomally expressing SBP1-FLAG and confirmed that the FLAG-tagged SBP1 retained the localization of wild-type SBP1 in Maurer's clefts (Figures 1A and 1B) .
Human erythrocytes were infected with 3D7 wild-type parasites, or parasites expressing SBP1-FLAG, and late trophozoite or schizont-enriched red blood cells (RBCs) were purified via Percoll gradient centrifugation and magnetic isolation. Whole-cell lysates were prepared, immunoprecipitated with an anti-FLAG antibody, and subjected to SDS-PAGE followed by western blot and silver staining. Although the bait protein was detected among the precipitants from the lysates of RBCs infected with SBP1-FLAG-expressing parasites ( Figure 1C ), multiple proteins were non-specifically bound to the immunoprecipitation beads and specific bands for immunoprecipitates from the SBP1-FLAG samples were not detected ( Figure 1D ). We, therefore, employed a highly sensitive shotgun proteomic approach, and compared the proteomes of the two precipitates. The SBP1-FLAG and 3D7 proteomes contained 1,381 and 1,367 proteins, respectively, with 1,125 ($81%) overlapping proteins ( Figure 1E and Table S1 ). No statistically significant differences were observed in the power of protein detection or protein coverage between the two proteomes, indicating that the proteomes were comparable (Figures 1F and 1G) . A total of 256 proteins, 51 host and 205 parasite proteins, was specifically detected in only the SBP1-FLAG proteome ( Figure 1E) ; however, these included many proteins with a relatively low Mascot protein score (Table S2) .
We then refined the list of proteins based on a comparison of their Mascot protein scores and identified 106 proteins (88 parasite and 18 host proteins) that specifically co-immunoprecipitated with SBP1 ( Figure 1H and Table S3 ; details are provided in the Transparent Methods). In addition to spectrin (SPTA1 and SPTB), a host factor known to interact with SBP1 (Blisnick et al., 2000; Kats et al., 2015) , we identified several parasite proteins, including PfEMP1, PIESP2, and PTP1, all of which form a large protein complex with SBP1 inside host cells Cooke et al., 2006; Maier et al., 2007; Mbengue et al., 2015; , as top-ranked hit proteins, thereby demonstrating the reliability of our approach relative to previous studies ( Figure 1I ). We next performed a functional enrichment analysis and categorized the potential SBP1 interactors according to subcellular compartments. Gene Ontology (GO) analysis identified Maurer's clefts (Benjamini-adjusted p = 1.6 3 10 À4 ), and the cytoskeleton (Benjamini-adjusted p = 0.032) as the most enriched by parasite and host proteins, respectively (Figure 2A ). In addition, most of the high-ranked GO terms for the parasite proteins were predominantly related to proteins exported to host cytoplasm (p = 1.6 -3.5 3 10 À4 ) ( Table S4 ). The GO analysis further identified enrichment in multiple parasite cellular compartments, including the Sec61 translocon complex (Benjamini-adjusted p = 0.0089), rough endoplasmic reticulum (Benjamini-adjusted p = 0.014), and nuclear pore (Benjamini-adjusted p = 0.024) (Figures 2A and 2B) . These results suggest that the identified proteins represent parasite proteins exported to the host cytoplasm, where SBP1 functions to anchor the Maurer's clefts to the host cytoskeleton (Blisnick et al., 2000; Kats et al., 2015) as well as proteins associated with the intracellular trafficking of SBP1 within the parasites.
To verify and validate our findings, we focused on the following 11 proteins: five parasite proteins that interacted with the Maurer's clefts (PIESP2, REX1, REX2, MAHRP1, and MAHRP2), three parasite proteins that have not previously been reported to interact with SBP1 (PF10_0018, STEVOR, and TryThrA), and three host proteins (STOM, KPNB1, and MPP1). To test whether these proteins interact with endogenous SBP1, we generated parasites expressing FLAG-tagged SBP1 under the control of endogenous promoters by introducing a FLAG tag after the full-length C terminus of SBP1 using single crossover homologous Figure 1 . An Unbiased Comparative Proteomic Approach to Identifying Proteins That Interact with SBP1 (A) Immunofluorescence assay on 3D7/SBP1-FLAG cells: the FLAG signal (green) co-localizes with that of endogenous protein (SBP1; red). Erythrocyte and parasitophorous vacuole membranes are circled by solid and dotted lines, respectively. Scale bar, 3 mm. (B) Western blot analysis of 3D7/SBP1-FLAG cells: parasite-infected RBCs were purified by magnetic-activated cell sorting (MACS), lysed with SDS/Triton lysis buffer, and equivalent amounts of samples were analyzed by western blot. (C and D) (C) Western blot and (D) silver stain analyses of proteins co-immunoprecipitated with SBP1-FLAG. The arrow indicates a bait protein (SBP1-FLAG). (E) Venn diagram comparing proteins identified in 3D7 and SBP1-FLAG proteomes. A total of 256 proteins were specifically detected in the SBP1-FLAG proteome. (F and G) (F) Average and (G) distribution of Mascot Protein Scores of proteins in two proteomic datasets. P values were calculated by using Mann-Whitney's U and Kolmogorov-Smirnov tests described in Transparent Methods supplemental file. (H) Unbiased comparative analysis of proteins in two proteomes based on Mascot protein score; 106 proteins were selected by fold change with a cutoff of 5.0. (I) Selected representatives of top-ranked proteins identified in the SBP1 interactomes. recombination ( Figure S1 ). Whole-cell lysates were prepared, and co-immunoprecipitation was carried out as described above. The precipitated proteins were subjected to SDS-PAGE followed by western blot using polyclonal serum from mice immunized with recombinant parasite proteins (details are provided in the Transparent Methods) and commercially available antibodies against the host proteins. We confirmed that all the 11 proteins tested co-immunoprecipitated with endogenous SBP1 by western blot analyses ( Figure 2C ). Of note, six of the parasite proteins (PIESP2, REX1, REX2, MAHRP1, STEVOR, and TryThrA) co-localized with SBP1 in the Maurer's clefts, whereas the remaining five proteins (two parasite proteins, PF10_0018 and MAHRP2, and three host proteins, STOM, KPNB1, and MPP1) showed partial co-localization with SBP1 ( Figure 2D ), presumably reflecting a different role for these proteins in the host cytoplasm; that is, the ''full'' co-localization proteins may be involved in the trafficking complex in the Maurer's clefts, whereas the ''partial'' co-localization proteins may be involved in anchoring the Maurer's clefts. Taken together, our unbiased comparative proteomic approach allowed us to systematically identify SBP1-interacting candidates and establish a comprehensive map of SBP1 interactomes in human erythrocytes infected with P. falciparum.
Host-Parasite Interactions Based on SBP1 Interactomes
Our identification of SBP1-interacting candidates sheds light on the complex interplay between multiple parasite proteins and SBP1 throughout the trafficking pathway and highlights plausible parasite-host (C and D) Biological binding and functional validation of 11 SBP1 interactors by use of co-immunoprecipitation (C) and immunofluorescence (D) assays on endogenous SBP1-FLAG cells. The asterisk indicates a non-specific band that reacted with the light chain of IgG. Scale bar, 3 mm. The ratio of co-localization between two factors was analyzed by using Python 3.7.3 and is shown as the mean G SD (n = 10). interactions in the host cytoplasm. Of the host proteins that interacted with SBP1, we focused on STOM and MPP1, which are involved in the membrane organization of erythrocytes (Biernatowska et al., 2017; Lach et al., 2012; Salzer and Prohaska, 2001) . To determine whether these proteins are associated with the erythrocyte cytoskeleton, we examined their solubility ( Figure 3A ). Solubility assays revealed that STOM remained exclusively in the pellet corresponding to membrane ghost fractions (similar to spectrin), whereas a portion of MPP1 was released into the detergent-sensitive supernatant fractions, suggesting the presence of soluble MPP1 in the host cytoplasm, consistent with previous studies (Biernatowska et al., 2017; Lach et al., 2012) .
To examine the effects of SBP1 on the localization of these two host proteins, we next generated SBP1-deficient transgenic parasites Maier et al., 2007) and analyzed the protein localization in erythrocytes infected with wild-type or DSBP1 parasites ( Figure 3B ). The absence of SBP1 did not influence the localization of these two proteins; the MPP1 signal was detected in the Maurer's clefts and infected RBC (iRBC) membrane regardless of whether SBP1 was present. To further examine whether MPP1 associates with SBP1 in Maurer's clefts, we performed immunoelectron microscopy using gold particle co-labeling of MPP1 and SBP1 ( Figure 3C ). We observed that MPP1 was closely associated with SBP1 in the Maurer's clefts, but that a portion of MPP1 was detectable just beneath the erythrocyte membrane where the SBP1 signal was not detected ( Figure 3C ). Thus, we identified the host protein MPP1 as being recruited into Maurer's clefts, suggesting that it may play a role in the membrane organization of these clefts.
Using SBP1 Interactomes to Reveal the Exportome
Previous proteomic studies of the protein components of the trafficking complex and of secreted microvesicles identified a limited number of exported proteins ( Figure S2 ). Our SBP1 interactomes highly enrich our knowledge of the known exported proteins identified in previous proteomic studies ( Figure S2 ) and reveal a previously unknown association between a host protein, MPP1, and the Maurer's clefts.
Among the 88 parasite proteins identified in our SBP1 interactomes, we found 63 proteins with the canonical PEXEL motif [(R/K)xLx(D/E/Q)], which is present in many exported proteins ( Figure 4A ). We focused on the following 16 proteins: 5 proteins with the PEXEL motif (PF10_0018, PF10_0020, PCNA2, PF08_0069, and PF10_0208) and 11 proteins lacking the PEXEL motif (ACS3, HGPRT, MAL7P1.170, PF07_0065, PFF0290w, PF14_0057, PFB0826c, ACS7, VP1, VPS29, and PF13_0012a), and re-examined their intracellular localization.
To test whether these proteins are exported into the host cytoplasm, we conducted a GFP-based protein export assay as established previously Spielmann et al., 2006) . The full length or N terminus of each candidate was C-terminally tagged with GFP and expressed episomally in P. falciparum. In parallel, GFP alone and GFP-tagged SBP1 and KAHRP were expressed and used as controls. The expression of the GFP-fused proteins of each mutant was confirmed by western blot ( Figure S3A ).
Of the mutant cell lines tested, three showed weak GFP fluorescence (PF10_0208, ACS3, and ACS7), nine showed no evidence of export (PCNA2, PF08_0069, HGPRT, PF07_0065, PFF0290w, PF14_0057, PFB0826c, VP1, and VPS29), and four showed export (PF10_0018, PF10_0020, MAL7P1.170, and PF13_0012a) ( Figures  4B and 4C ). For the three mutants showing weak GFP fluorescence, we performed immunofluorescence staining using an a-GFP antibody and showed no evidence of export ( Figure S3B ). Of the four exported proteins, PF10_0018-GFP, PF10_0020-GFP, and MAL7P1.170-GFP were distributed throughout the host cytoplasm, whereas PF13_0012a-GFP produced characteristic fluorescence in the Maurer's clefts. Figure S3A . The results of immunofluorescence assays using anti-GFP antibodies on three mutants showing weak GFP fluorescence (indicated by the asterisk) are shown in Figure S3B . (D) Western blot analyses using anti-GFP with extracts from selective permeabilization assays show bands with full-length or truncated versions of four exported GFP fusion proteins. SN, supernatants; Tet, tetanolysin (host cytosol); Sap, saponin (Maurer's clefts and parasitophorous vacuoles); P, pellet (final pellet); REX3, soluble parasite proteins in host cells; EXP2, parasitophorous vacuole marker. Asterisk, degradation product.
To define the subcellular localization of the four exported proteins, we conducted a selective permeabilization assay on erythrocytes infected with each mutant parasite (Boddey et al., 2016; Mantel et al., 2016) ( Figure 4D ). Sequential treatment of iRBCs with tetanolysin and saponin separates the cells into RBC cytosol, a parasitophorous vacuole and Maurer's clefts, a parasite membrane fraction, and a host membrane fraction (Mantel et al., 2016) . Western blot analyses demonstrated that all four exported proteins were present in the soluble fractions representing RBC cytosol, thereby confirming the observed localization of these proteins in the live-cell imaging analyses ( Figure 4D ). Thus the SBP1 interactomes established by our alternative proteomic approaches led us to discover four exported proteins regardless of whether they contained the PEXEL motif.
Necessity and Significance of SBP1-Interacting Proteins
In light of the functional importance of SBP1 for the host cell remodeling that is required for malaria virulence, we asked whether disruption of genes encoding SBP1 interactors could affect malaria survival and pathogenesis. To concentrate on genes that encoded exported proteins for knockout experiments, we first curated a list of genes by selecting those specifically expressed during the ring stage from Table S2 , as well as the top-ranked 25 hit genes from Table S3 , resulting in a set of 37 genes. This set contained seven genes that encode well-known exported proteins required for malaria virulence (SBP1, MAHRP1, MAHRP2, REX1, REX2, PTP1, and PTP5) ( Figure S4 ). We therefore focused on 13 SBP1-interacting genes (PF10_0018, ACS3, PF13_0309, PF08_0069, vapA, FIKK10.2, TryThrA, ACS7, VP1, STARP, PFL2530w, PF14_0045, and MAL8P1.4) whose functions remain to be fully elucidated, plus SBP1, and performed targeted gene disruption experiments by using the double homologous recombination system described previously (Figures S5 and S6 ).
Of 14 genes tested, seven (SBP1, PF10_0018, FIKK10.2, TryThrA, STARP, PFL2530w, and MAL8P1.4) could be genetically disrupted, suggesting that the other seven genes are essential to the parasite during the asexual blood stage (Figures 5A and S4-S6). Of the seven genes that were disrupted, six encode exported proteins (SBP1, PF10_0018, FIKK10.2, TryThrA, STARP, and MAL8P1.4), which is consistent previous findings that genes encoding exported proteins are less essential for parasite asexual development than those encoding non-exported proteins (Bushell et al., 2017; . We did not see any substantial differences in parasite growth or invasion between the wild-type parasite and each knockout mutant (Figures S7A and S7B) . These results suggest that the exported proteins encoded by these six genes may play roles in host cell remodeling by interacting with SBP1.
We then focused on three knockout cell lines (DTryThrA, DSTARP, and DMAL8P1.4), in which genes that encoded proteins located in Maurer's clefts were disrupted, and tested their cytoadherence by using a CD36 static binding assay. We found that DTryThrA and DSTARP showed comparable levels of cytoadherence relative to those of the wild-type, whereas disruption of the MAL8P1.4 gene resulted in increased cytoadherence of iRBCs to CD36 ( Figure 5B ). Intriguingly, we did not observe any changes in the localization of known exported proteins, represented by SBP1, PfEMP1, MAHRP1, and REX1, or any alternations in knob formation or Maurer's cleft morphology in the erythrocytes infected with DMAL8P1.4 parasites compared with those in the erythrocytes infected with wild-type parasites ( Figures S7C-S7G ). Thus, by performing gene knockout experiments followed by cytoadherence assays on 14 genes that encode potential SBP1 interactors, we identified MAL8P1.4 as being associated with the cytoadherence of iRBCs and thereby affecting malaria virulence.
DISCUSSION
Here, we developed an authentic, unbiased, and highly sensitive comparative proteomic approach to characterize proteins that interact with SBP1. This approach allowed us to identify more than 100 putative proteins, which were enriched with known exported proteins that play central roles in host cell remodeling. On the basis of SBP1 interactomes, we further conducted systematic analyses to validate the factors that were associated with SBP1 in the cytoplasm of erythrocytes ( Figure 5C ) and identified a parasite protein, MAL8P1.4, which regulates the cytoadherence of P. falciparum-infected erythrocytes to vascular endothelial receptors.
Regarding the quality of the interactome we have presented, it must be noted that we cannot exclude the possibility that our dataset contains false-positives. However, by performing validation studies on previously known and unknown SBP1-interacting proteins, we have been able to show that our SBP1 interactomes are reliable and invaluable for the clarification of the exportome. This significantly increases the value of our dataset as a resource because the entire dataset used for our analyses is presented here and can be analyzed independently. It is also important to note that our established system to identify SBP1interacting proteins is completely authentic and unbiased regarding protein identification. Because of technical difficulties using co-immunoprecipitation to study protein-protein interactions in the cytoplasm of erythrocytes infected with parasites, most previous interactome studies Dietz et al., 2014; Oberli et al., 2016) have been done on parasite lysates after saponin lysis to remove the host cell cytosol, Maurer's clefts, and soluble parasitophorous vacuole contents. This is because erythrocytes contain abundant cytoskeleton proteins, which easily and non-specifically bind to beads, leading to loss of important information regarding protein interactions in the host cytoplasm. To overcome these difficulties, we carried out co-immunoprecipitation experiments on whole-cell lysates of purified iRBCs, analyzed the precipitated proteins by using shotgun proteomics, and performed quantitative analyses of the two proteomes obtained. The dataset derived by taking this approach includes many of the exported proteins previously characterized. In fact, our proteomic data covered 16 of the known exported proteins Figure 5 . Necessity and Significance of SBP1 Interactors for Parasites in the Asexual Blood Stage (A) Genes selected for knockout studies. Shown in the first to fourth columns are the accession number, previous ID, gene symbol, and gene description from PlasmoDB (http://www.plasmo.org). The fifth column shows the subcellular localization of the protein in the infected erythrocyte if known and whether or not the protein is exported based on the results of the protein export assay shown in Figure 4 . The sixth column shows a transcriptional profile where yellow denotes an increased period of transcription and blue denotes a decreased period or no transcription. Gene expression data were obtained from the DeRisi's microarray data available in PlasmoDB. R, ring; T, trophozoite; S, schizont asexual life cycle stages. The seventh column shows the Protein Mascot Score of each protein in the SBP1-FLAG/3D7 proteomes; -denotes not detected. The eighth column refers to whether the gene can be genetically disrupted (Yes) or not (No) . Asterisk, undetermined because of delayed growth of parasites transfected with gene-targeting plasmid. (B) Adherence of mutant parasite-infected erythrocytes to CD36 receptors under static conditions. Two clones of each mutant parasite were tested for binding to CD36 receptors; adherent cells were counted and are shown as a ratio relative to the level of 3D7-infected erythrocytes. The values presented are the average of three independent experiments G SD. P values were calculated by using one-way ANOVA with Tukey's post-hoc test (*P < 0.05). (C) Overview of the protein-protein interactions uncovered by our SBP1 interactomes. Three host proteins (STOM, KPNB1, and MPP1), two parasite proteins (PF10_0018, and PF10_0020), and six parasite exported proteins (STEVOR, Pf332, TryThrA, STARP, PF13_0012a, and MAL8P1.4) identified in our study are shown in boldface. Proteins involved in cytoadherence are underlined.
(PfEMP1, FIKK10.1, PTP1, PFF0090w, PFA0210c, GEXP10, SBP1, PIESP2, REX1, MAHRP1, MAHRP2, Pf332, REX2, PFE0050w, GEXP07, and MC-2TM) of the 21 overlapping proteins identified in three previous proteomic studies . Our study further confirmed that these proteins made authentic interactions in the host cytoplasm ( Figure S2 ). With these advantages, our SBP1 interactomes could serve as intermediaries to connect previous studies Dietz et al., 2014; Oberli et al., 2016; of exported proteins. The application of our proteomic approaches to other exported proteins resident in Maurer's clefts would greatly increase our understanding of the interaction network of the P. falciparum exportome.
Recently, the P. falciparum orthologs of SBP1 and MAHRP1 were discovered in the rodent malaria Plasmodium berghei by De Niz et al. (De Niz et al., 2016) , and disruption of these genes resulted in the decreased cytoadherence of iRBCs to CD36 in a mouse model, suggesting that these genes are likely involved in the transport of an unidentified parasite ligand that allows binding of iRBCs to vascular endothelium, similar to P. falciparum SBP1 and MAHRP1 Maier et al., 2007; Spycher et al., 2008) . Given that our proteomic studies identified a solid interaction between SBP1 and PfEMP1, our approach could be used to identify such unidentified parasite ligands of rodent malaria.
Our analyses led us to identify three parasite proteins (PF10_0018, STEVOR, and TryThrA) associated with the trafficking complex, as well as several host-parasite protein interactions (STOM, KPNB1, and MPP1). PF10_0018 was identified as a highly ranked SBP1 interactor, and its homolog PF10_0020 was also identified with a high probability-based score in our proteomic analyses (see Tables S2 and S3 ). These two genes encode proteins that belong to the a/b hydrolase family, have the highest sequence similarity in our study ( Figure S8 ), and were recently shown to be efficiently exported (Spillman et al., 2016) . However, their roles in the host cytoplasm remain completely unknown. Given the predicted lysophospholipase activity of PF10_0018 and PF10_0020, and that a variety of pathogens exploit host lipids to modify their membrane compositions (van der Meer-Janssen et al., 2010), these proteins might play a role in the lipid metabolism required for the generation of Maurer's clefts.
A tryptophan-threonine-rich antigen (termed by TryThrA) was also identified as a parasite protein associated with SBP1 in the trafficking complex. TryThrA was previously characterized as a protein expressed on merozoite surface and involved in parasite invasion, which is supported by the inhibitory effect of synthetic peptides of TryThrA antigen on merozoite invasion of erythrocytes (Curtidor et al., 2006 ). In the current study, we found that TryThrA was expressed across the asexual cycle and localized in Maurer's clefts (See Figure S9 ). Moreover, we demonstrated that its gene could be genetically disrupted without affecting parasite invasion ( Figure S7B ), which is inconsistent with previous studies (Alam et al., 2015; Curtidor et al., 2006) . This discrepancy could be explained by off-target effects of the synthetic peptides used in the previous studies, or by alternative expression of molecules that could compensate for the loss of TryThrA in our knockout parasites. Further studies are warranted to elucidate the precise function of TryThrA in infected erythrocytes.
Host-parasite protein interactions play an essential role in malaria progression and pathogenesis (Egan et al., 2015; Miller et al., 2002; Olszewski et al., 2009 ). Here, we identified several host-parasite protein interactions in the host cytoplasm. Of three host factors identified (STOM, KPNB1, and MPP1), we found that MPP1, membrane palmitoylated protein 1 (also termed p55, 55 kDa erythrocyte membrane protein), was recruited into the Maurer's clefts ( Figure 3C ). MPP1 is a member of the membrane-associated guanylate kinase (MAGUK) family and plays essential roles in membrane organization of erythroid cells, composition of lipid rafts on erythrocyte membranes, and erythrocytopoiesis (Biernatowska et al., 2017; Egan et al., 2015; Lach et al., 2012; Quinn et al., 2009) . Moreover, a previous proteomic study of microvesicles, which are secreted from the surface of P. falciparum-infected erythrocytes and likely bud from Maurer's clefts , identified the presence of this protein. These results suggest that MPP1 might contribute to the organization of the membranous structures of Maurer's clefts.
Our series of knockout experiments followed by cytoadherence assays on potential SBP1 interactors identified MAL8P1.4 as being involved in the cytoadherence of iRBCs to vascular endothelial receptors (Figure 5B ). MAL8P1.4 is a member of the Plasmodium helical interspersed subtelomeric (PHIST) family of exported proteins, which play diverse roles in parasite-infected erythrocytes (Kumar et al., 2018; Oberli et al. 2014 Oberli et al. , 2016 Proellocks et al., 2014) . Although the function of PHIST genes remains to be fully elucidated, previous studies have revealed that specific PHIST proteins can bind to the acidic C-terminal (ATS) domain of PfEMP1 and that depletion of genes that encode PHIST proteins results in decreased cytoadherence (Oberli et al., 2016; Proellocks et al., 2014) . Moreover, the binding capacity of a PHIST protein differs for each PfEMP1 depending on the sequence of its ATS domain (Kumar et al., 2018; Oberli et al., 2016) , suggesting that PHIST genes might have coevolved with specific ATS domains to create interaction pairs with maximum binding strength to transport a specific PfEMP1 to the erythrocyte membrane (Kumar et al., 2018; Oberli et al., 2014; Proellocks et al., 2014) . In contrast, it has also been reported that MAL8P1.4 does not localize to the surface of erythrocytes or a knob and has low binding affinity for an ATS domain of a specific PfEMP1 (Oberli et al., 2014) . Although there are many unknowns regarding the function of MAL8P1.4, given that multiple PHIST proteins are cooperatively and selectively involved in the transport of a specific PfEMP1 to the erythrocyte surface (Oberli et al., 2016) , the altered cytoadherence by DMAL8P1.4 parasites may arise from the alternation of PfEMP1 being transported and presented on the erythrocyte surface. Further investigations of the relationships between cognate genes, in addition to a genetic complementation study of the MAL8P1.4 gene, would reveal the mechanistic details of the cytoadherence required for malaria virulence.
In summary, we present a comprehensive map of SBP1 interactomes to better understand the intraerythrocytic trafficking complex and interactions between host and parasite proteins in the host cytoplasm. We used this information to identify exported proteins required for cytoadherence of P. falciparum-infected erythrocytes and found that disruption of MAL8P1.4 resulted in altered cytoadherence of iRBCs to endothelial receptors with no appreciable effects on parasite viability or host cell remodeling. These findings demonstrate that our original approach using unbiased comparative shotgun proteomics provides significant insights into the complicated interplay between host and parasite proteins in the trafficking complex and creates pathways to study the molecular basis of the virulence of P. falciparum-infected erythrocytes.
Limitation of the Study
The present study led us to identify multiple host-and parasite-derived proteins that interact with SBP1, but it did not lead to the detailed function elucidation of the identified factors. Detailed analyses of how MPP1 or MAL8P1.4 is involved in the formation and configuration of Maurer's clefts, as well as cell adhesion, are needed. Moreover, to determine whether our results are universally applicable, further studies using different P. falciparum strains should be done.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.07.035.
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Parasites and cell culture. The P. falciparum 3D7 clone was obtained from the Malaria Research and Reference Reagent Resource Center (MR4; American Type Culture Collection, Manassas, VA). The parasites were continuously cultured in RPMI/HEPES medium (Sigma-Aldrich) supplemented with 100 μM hypoxanthine (Wako), 10 μg/ml gentamycin (Sigma-Aldrich), 1.5 mg/ml NaHCO 3 (Wako), and 5 mg/ml Albumax II (Invitrogen), as described previously (Trager and Jensen, 2005) . Parasites were synchronized either by D-sorbitol (Wako) treatment (Lambros and Vanderberg, 1979) , by Percoll (GE Healthcare) gradient (Kramer et al., 1982) , by MACS separation (Ribaut et al., 2008 ) (LD column, Miltenyi Biotec), and/or by gelatin floatation (Jensen, 1978) . Human RBCs (blood type A+, O+, or AB+) were obtained from healthy volunteers under appropriate informed consent, and used in the study.
DNA and RNA extractions.
Parasite lysates were prepared by saponin lysis of parasite-infected erythrocytes, as essentially described previously (Boddey et al., 2016) . Genomic DNA and total RNAs were extracted from parasite lysates by using the Nucleospin Tissue (Marcherey-Nagel), and SV Total RNA Isolation System (Promega), respectively. Extracted total RNA was reversely transcribed to cDNA with oligo(dT) primers and SuperScript TM III reverse transcriptase (Invitrogen) according to the manufacturer's instructions.
Transgenic parasites.
To generate parasites episomally expressing C-terminally FLAG-or GFP-tagged proteins, the protein coding regions of interest were amplified from parasite cDNA using the specific primers listed in Table S5 , and cloned into the expression vectors C-Flag-pHC1 or pARL1-GFP, respectively. C-Flag-pHC1 vector, which encodes a FLAG epitope and an upstream site for the generation of FLAG-tagged proteins, was generated based on the pHC1 vector (Crabb et al., 1997) , which contains the DHFR-TS gene that encodes resistance to pyrimethamine. The pARL1-GFP vector, which expresses GFP-tagged proteins under the control of the crt promoter and contains the hDHFR gene that confers resistance to WR99210, was generated based on the pARL1-KAHRP-GFP vector (Knuepfer et al., 2005; , which was a kind gift from Dr. Alan F. Cowman (Walter and Eliza Hall Institute, Australia). Briefly, the vector was cut with XhoI to remove the KAHRP-GFP fragment, and the protein coding regions to be tested were PCR-amplified and either inserted into the XhoI site of the vector simultaneously with PCR-amplified GFP fragments using an In-Fusion Cloning kit (Clontech), or were subcloned into the NotI site of the C-GFP-pHC1 vector, which encodes GFP and an upstream site for the generation of GFP-tagged proteins. In the latter, the coding regions of the GFP-fused proteins were further PCR-amplified and cloned into the corresponding sites of pARL1. To generate parasites expressing FLAG-tagged SBP1 under the control of the endogenous promoter, the 3'-terminal genomic region of SBP1 (~1.0 kb) was PCR-amplified from parasite genomic DNAs, and cloned into the C-Flag-pHC1 vector as described above. For the generation of knock-out mutants, the allelic exchange fragments composed of approximately 0.6-1.0 kb were PCR-amplified from parasite genomic DNAs, and cloned into the SacII/SpeI and EcoRI/NcoI sites of the pHHT-TK vector, which contains the hDHFR cassette and a negative selection cassette to select parasites in which double recombination events had occurred (Duraisingh et al., 2002) . PCR was carried out by using KOD-plus-DNA polymerase (TOYOBO, Japan), and the plasmid DNA was extracted using Maxiprep kits (Invitrogen). Prior to use, all of the plasmids were sequenced to ensure the absence of any unwanted mutations.
Plasmid transfection was conducted by electroporation as previously described . Briefly, red blood cells were pre-loaded with 50-200 μg of plasmid DNAs, and mixed with purified late stage parasites at a final parasitemia of 0.1%. Transfectants were selected by the addition of 50 nM pyrimethamine (Sigma-Aldrich) or 5 nM WR99210 (Jacobus Pharmaceuticals) to the culture medium, starting 72 h post-transfection. Once the transgenic parasites were established, the drug concentration was increased to 2 μM pyrimethamine or 20 nM WR99210. To obtain knock-out parasites, the genomes of which were replaced by vector sequences, parasites after positive selection on WR99210 were placed under negative selection using 4 μM ganciclovir (Wako) in addition to WR99210. If no parasites were recovered, the negative selection was repeated at least twice. Mutant parasites were cloned by limiting dilution and at least two clones for each mutant were used for subsequent analyses.
Generation of recombinant proteins and antiserum.
The antibodies against parasite proteins were generated by immunization of mice with recombinant proteins expressed by the Wheat Germ Cell-Free System (WGCFS, Cell-Free Inc., Japan) as described (Tsuboi et al., 2008) . Briefly, the protein coding regions of the following 14 genes were PCR-amplified with the indicated primers listed in Table S5 : PfEMP1 A mouse (5-to 8-week-old female BALB/c strain, CLEA Japan, Inc.) was injected subcutaneously with 2-20 μg of each purified recombinant protein with Titermax Gold Adjuvant (Funakoshi), and the immunization was boosted at 7-10 day intervals three times. If necessary, a booster immunization was given up to 5 times to obtain polyclonal mouse serum. The antisera were tested for specificity prior to use by immunoblot analyses on cell lysates prepared from MACS-purified or saponin-treated erythrocytes, and by immunofluorescence analyses of blood smears of parasite-infected erythrocytes.
Antibodies.
The mouse and rabbit anti-SBP1, and the rabbit anti-EXP2 antibodies were kind gifts from Dr. Takafumi Tsuboi (Ehime University, Japan). The mouse anti-FLAG epitope tag (F1804, Sigma-Aldrich), anti-FLAG M2-Affinity Gel (A2220, Sigma-Aldrich), mouse anti-GFP (mFX73, Wako), mouse anti-spectrin (α and β) (S3396, Sigma-Aldrich), rabbit anti-STOM (HPA010961, Atlas Antibodies), rabbit anti-KPNB1 (LS-B11745, LifeSpan Biosciences Inc.), and mouse anti-MPP1 (ab55464, Abcam; SAB1404080, Sigma-Aldrich) were purchased from the commercial sources indicated. The polyclonal antisera raised from mice immunized with the recombinant parasite antigens described above were available in our laboratory. The following antibodies were used as secondary antibodies: goat anti-mouse IgG Alexa 488 (A11001, Life Technologies), goat anti-rabbit IgG Alexa 488 (A11008, Life Technologies), donkey anti-mouse IgG Alexa 594 (A21203, Life Technologies), goat anti-rabbit IgG Alexa 594 (A11037, Life Technologies), HRP-conjugated anti-mouse IgG antibody (NA9310V, GE Healthcare), HRP-conjugated anti-rabbit IgG antibody (NA9340V, GE Healthcare), gold-conjugated (15 nm) goat anti-mouse IgG (AC-15-02-05, Cytodiagnotics), gold-conjugated (5 nm) goat anti-rabbit IgG (AC-5-01-05, Cytodiagnotics) antibodies, and gold-conjugated (5 nm) Protein G (AC-5-18-05). The following antibodies were used only for western blotting: HRP-conjugated mouse anti-FLAG (A8592, Sigma-Aldrich), HRP-conjugated rabbit anti-GFP (598-7, MBL), HRP-conjugated rabbit anti-GST tag (PM013-7, MBL), and HRP-conjugated mouse anti-His tag (D291-7, MBL) antibodies.
Immunoprecipitation and mass spectrometry analysis.
Immunoprecipitation followed by shotgun proteomics were carried out as previously described with some modifications. Briefly, 100 μl of
MACS-purified erythrocytes (> 90% infected cells) were incubated with lysis buffer [50 mM
Tris-HCl (pH 8.0) (Invitrogen), 150 mM NaCl (Ambion), 2.0% Nonidet P-40 (NP-40, Sigma-Aldrich), and protease inhibitors (Complete Mini, Roche)] for 1 h at 4 ºC. After clarification by centrifugation to remove cellular debris, the supernatants were incubated with an anti-FLAG M2-Affinity Gel (Sigma-Aldrich) for 17 h at 4 ºC. The affinity gels were washed thoroughly with lysis buffer without protease inhibitors, and then washed twice with immunoprecipitation (IP) buffer (50 mM Tris-HCl and 150 mM NaCl). Proteins bound to affinity gels were eluted with elution buffer [50 mM Tris-HCl, 150 mM NaCl, and 0.5 mg/ml FLAG peptide (Sigma-Aldrich)] for over 4 h at 4 ºC. After the gel was removed by centrifugation, the supernatants were filtered by using an Ultrafree-MC filter (Millipore). Filtered samples were subjected to SDS/PAGE followed by silver staining, western blotting, or mass spectrometric analysis.
For mass spectrometric comprehensive detection, eluted proteins were trypsinized and subjected to shotgun proteomic analyses to identify co-immunoprecipitated proteins. For this analysis, we used a linear ion trap-orbitrap mass spectrometer (LTQ-Orbitrap Velos, Thermo maximum missed cleavages, 2; peptide mass tolerance, 3 ppm; MS/MS tolerance, 0.8 Da. In the process of peptide identification, we conducted decoy database searches using Mascot and applied a filter to satisfy a false positive rate lower than 1%.
Bioinformatics.
To ensure the comparability of the two proteomic datasets, we first statistically compared the power of detection and proteome coverage for the proteomic data obtained from 3D7-infected erythrocytes with those obtained from SBP1-FLAG-infected erythrocytes. Mascot protein scores and their distributions were analyzed by using Mann-Whitney's U and Kolmogorov-Smirnov tests, respectively. A protein was considered an SBP1-interacting candidate if it satisfied either of two different criteria, resulting in two datasets, that is, one set containing proteins that were identified only in the SBP1-FLAG proteome and not in the 3D7 proteome (number of proteins = 256; median Mascot protein score = 61.1, Table S2 ), and the second containing proteins with a fold change greater than 5.0 (corresponding to ~1.5σ for Gaussian variables) in Mascot protein scores of the SBP1-FLAG proteome relative to those of the 3D7 proteome (number of proteins = 106; median Mascot score = 157.1, Table S3 ).
Functional enrichment analyses of the SBP1-interacting factors were carried out using the Gene Ontology (GO) analyses in the DAVID (https://david.ncifcrf.gov/) and PlasmoDB databases (http://plasmodb.org/plasmo/) for host and parasite proteins, respectively. The relationships between GO terms were visualized using the Cytoscape 3.3.0 software with the ClueGO plugin . The GO analyses were conducted using a right-sided hypergeometric test with Benjamini-Hochberg correction; values were considered to be significant when the P value was less than 0.05. The GO term levels were set from one to eight.
The minimum number of genes to form a cluster was set at two, while the minimum percentage of genes covered by our dataset against the database was set at 1%. The rest of the setting were left as defaults. The resultant Fig. 2A shows the top GO terms (cellular components) of the parasite-derived 88 SBP1-interacting factors identified in Table S3 , whereas Fig. 2B shows the relationships between the top GO terms.
SDS-PAGE and western blotting.
Protein extracts from parasite-infected RBCs were separated by SDS-PAGE in gradient precast 5%-20% polyacrylamide gels (e-PAGEL, E-R520L; ATTO), and blotted onto PVDF membranes (Bio-Rad). Membranes were probed with primary antibodies at the following dilutions (in 5% blocking agent in PBS): rabbit anti-SBP1, 1/5000; mouse anti-SBP1, 1/1000; mouse anti-FLAG, 1/1000; rabbit anti-EXP2, 1/2000; mouse anti-spectrin, 1/20; rabbit anti-STOM, 1/100; rabbit anti-KPNB1, 1/400; mouse anti-MPP1, 1/20. Mouse anti-sera obtained in this study were used at dilutions ranging from 1/10 to 1/500. Secondary antibodies were horseradish peroxidase (HRP)-conjugated goat anti-mouse and goat anti-rabbit, both used at 1/1000.
Live fluorescence and immunofluorescence.
Live cell imaging assays were conducted as described previously . The parasite nuclei were stained with 1 μg/ml DAPI (Invitrogen) for 30 min at RT. Indirect immunofluorescent assays were conducted either on blood smears on glass slides or by using an alternative method (Tonkin et al., 2004) . In the latter method, the cells were washed in PBS once, and fixed with 4% paraformaldehyde (Wako) and 0.0075% glutaraldehyde (Wako) in PBS for 30 min at RT. After centrifugation and being washed with PBS twice, the cells were permeabilized with 0.1% Triton X-100 (Sigma) in PBS for 10 min at RT.
After centrifugation and being washed in PBS, the samples were blocked with blocking reagent (Blocking One, Nacalai Tesque) for 1 h at RT, and incubated with primary antibodies in 5% blocking reagent in PBS for 1 h at RT. They were then rinsed with 0.1% Tween 20 in PBS (PBS-T) three times, and incubated with secondary antibodies for 1 h at RT. Finally, the samples were washed three times in PBS-T and mounted on glass slides with mounting medium (Dako). Coverslips were then inverted onto the glass slides, which were subsequently observed under the Leica TCS SP5 II confocal laser microscope equipped with a 100X/1.4 numerical aperture oil immersion lens. Images were collected and processed with LAS AF software (Leica).
Time course analysis.
To determine the expression and localization of parasite proteins in the asexual stage of parasite development, time course analysis was performed as previously described . Briefly, cells were tightly synchronized by repeated D-sorbitol treatment (Lambros and Vanderberg, 1979) , and subjected to either immunofluorescence or western blot analyses. For the latter, cell samples (50 μl of packed iRBCs, 5%-10% parasitemia) were taken every 8 hours after invasion from the same culture dish. The cells were lysed with 0.09% saponin in PBS for 15 min on ice, thoroughly washed with PBS three times, and cell pellets were completely dissolved in 50 μl of 4% SDS/0.5% Triton X-100/0.5 × PBS. Then, 50 μl of the cell lysate was mixed with the same volume of 2 × SDS sample buffer, boiled for 5 min, and subsequently subjected to SDS/PAGE followed by western blot analysis.
Subcellular fractionation assay.
To define the protein subcellular localization, selective permeabilization assays on parasite-infected RBCs were conducted (Boddey et al., 2016; , with some modifications. Briefly, iRBCs were MACS-purified, washed with PBS once, and lysed with 5 U/ml tetanolysin (List biological Lab.) in PBS for 20 min at 37 ºC. After centrifugation for 5 min at 15,000 rpm, the tetanolysin pellet was washed with PBS once, and further sequentially lysed with 0.03% saponin (Sigma) in PBS for 20 min on ice. After centrifugation, the resultant pellet was washed with PBS twice, and dissolved in 4% SDS/0.5% Triton X-100/0.5 × PBS.
Equivalent amounts of supernatants and pellet were analyzed by western blotting.
Cytoadherence assays.
The adhesive properties of iRBCs to the receptor CD36 were quantified using static-based assays as described previously (Beeson et al., 1999; Beeson et al., 1998; Oberli et al., 2016; Saito et al., 2017) . Briefly, 5 μl of recombinant human CD36 (100 μg/ml, R&D systems) was immobilized on 90 × 15-mm polystyrene dishes (Sansei Medical Co., Ltd., Kyoto) and incubated overnight at 4 ºC in a humid container. The protein spots were then blocked with 1% BSA in PBS for 30 min at room temperature and washed twice with pre-warmed protein binding medium (RPMI-1640 medium containing 0.1% bovine serum albumin). Trophozoite-or schizont-infected erythrocytes were purified by gelatin sedimentation, resuspended to 0.5% hematocrit in protein binding medium, then spotted onto immobilized proteins, and incubated for 30 min at 37 ºC. Prior to binding assays, parasite cultures were subjected to gelatin sedimentation three times to enrich for knob-positive parasites as described elsewhere (Dixon et al., 2017) . Unbound erythrocytes were removed by gently flooding each spot with binding medium, rocking the dish back and forth, then pouring off and replacing the medium five times. Bound cells were then fixed with 2% glutaraldehyde in PBS for 2 h at room temperature, stained with DAPI overnight, and counted by using a fluorescence microscope (BZ-X700, KEYENCE, Tokyo, Japan). The number of infected erythrocytes bound to the receptor was determined by counting ten fields using a 30× objective and is expressed as a ratio relative to the number of P. falciparum 3D7-infected erythrocytes.
Growth and invasion assay.
Growth and invasion assays were performed as previously described (Baldi et al., 2000; Reed et al., 2000) , with some modifications. For growth assay, tightly synchronized ring stage parasites were added to fresh erythrocytes at a final parasitemia of 0.3%, and hematocrit of 0.5% in 1 mL of culture medium in the absence or presence of drugs. The final concentrations of each drug in medium were: 20 U/mL for heparin (Novo heparin, Mochida Pharmaceutical, Tokyo, Japan), and 20 μM for pyrimethamine (Sigma). The medium was changed daily, and the parasitemia were counted by blood smear every 24 hours post-incubation for 2 cycles of parasite growth. For the invasion inhibition assay, parasite cultures were tightly synchronized with a cycle window of 3 hours, and MACS-purified schizont cultures were added to fresh erythrocytes at a final parasitemia of 0.4% or 5% for parasitemia count or indirect immunofluorescence analyses, respectively. Thin blood smears were prepared at 1, 3, and 6 hours post-invasion, and were subsequently analyzed for further experiments.
Electron microscopy.
Scanning electron microscopy (SEM) was performed as previously described (Rug et al., 2006) .
The infected RBCs were purified by gelatin flotation, washed with PBS twice, and fixed with glutaraldehyde (2% in PBS) for 30 min at RT. The erythrocytes were then washed with PBS twice, and settled onto APS-coated glass slides (Matsunami Glass Inc., Ltd., Osaka, Japan) for 30 min. The cells were washed three times in 0.1 M PB (pH 7.4), and further fixed in osmium tetroxide (1% in 0.1 M PB) for 30 min at RT. After fixation, the cells were dehydrated in an ascending series of ethanol (70%, 80%, 90%, 95%, 100%, 3×100%; 5 min each), transferred into 2-Methyl-2-propanol, and dried in a freeze dryer (ES-2030; Hitachi Koki Co., Ltd., Tokyo, Japan). The dried samples were coated with platinum-palladium in an ion sputtering device (E1010; Hitachi Koki Co., Ltd.), and observed with the SE mode of a field emission SEM (S-4100; Hitachi High Technologies).
Transmission electron microscopy (TEM) was performed as previously described (Rug et al., 2006) , and samples were viewed in an HT7700 transmission electron microscope (Hitachi, Tokyo, Japan). Immunoelectron microscopic examination (IEM) by TEM was conducted as previously described (Tonkin et al., 2004; . Briefly, the infected RBCs were purified by Percoll gradient or gelatin floatation, washed with PBS once, and fixed with 2% paraformaldehyde (Wako) in PBS for 10 min at RT. The cells were then washed in PBS three times, and permeabilized with 10 U/ml tetanolysin for 20 min at 37 ˚C. They were then washed in PBS twice and re-fixed with 4% paraformaldehyde and 0.0075% glutaraldehyde (Wako) in PBS for 30 min at RT. Then, the cells were washed in PBS twice, blocked with blocking reagent (Blocking One, Nacalai Tesque) for 1 h at RT, and incubated with primary antibodies for 1 h at RT. They were then rinsed with 0.1% Tween 20 in PBS (PBS-T) three times, and incubated with the appropriate secondary antibody conjugated with gold nanoparticles for 1 h at RT. The cells were rinsed again in PBS-T three times, and post-fixed with 2.0% glutaraldehyde in 0.1 M sodium cacodylate buffer and then with 1% OsO 4 in 0.1 M phosphate buffer (pH 7.4) for 30 min at RT. Then, the cells were serially dehydrated and embedded in LR White resin (London Resin Company Ltd., London, UK). Ultrathin sections (90-nm thick) were cut and examined using an HT7700 transmission electron microscope without uranyl acetate or lead citrate staining.
Phylogenetic analyses.
To investigate the phylogenetic relationships among genes containing the alpha/beta hydrolase domain, the protein sequences coding alpha/beta hydrolase were retrieved from the PlasmoDB database, and were phylogenetically analyzed as previously described (Takano et al., 2009) .
Maximum likelihood analyses were carried out on the protein regions encoding the alpha/beta hydrolase domain. Bootstrap support values were calculated from 1000 replicates using maximum likelihood and the preferred model of evolution (Takano et al., 2009) . To investigate the similarity of gene expression in the intraerythrocytic stage of the parasites, gene expression data of DeRisi's microarrays were retrieved from PlasmoDB. Hierarchal clustering analyses of the gene expression profiles of the 205 proteins in Table S2 were performed on R software ver.
2.15.2. (https://www.r-project.org/) as described elsewhere (Langfelder and Horvath, 2008) .
Statistical tests.
All statistical analyses were performed by using R software ver. 2.15.2 (https://www.r-project.org/). If not specified, all statistical analyses used one-way ANOVA with Tukey's post-hoc test (normal distribution assumed). For all statistical tests, values were considered to be significantly different when the P value was less than 0.05.
